Compare Huntington Ingalls Industries Inc (HII) vs Medtronic PLC (MDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Huntington Ingalls Industries Inc vs Medtronic PLC — how do they compare? Huntington Ingalls Industries Inc trades at $265.66 (market cap $10.44B), while Medtronic PLC trades at $88.16 (market cap $112.24B). The key difference: Medtronic PLC is far larger — about 10.8× Huntington Ingalls Industries Inc's market cap, and Medtronic PLC pays the higher dividend (3.28%). Which is the better fit depends on your goals — on Pluang, investors hold Huntington Ingalls Industries Inc for 28 Days and Medtronic PLC for 63 Days on average.
| HII | MDT | |
|---|---|---|
Market Cap | $10.44B | $112.24B |
Volume | 440,462 | 105,663,236 |
Sector | Industrials | Health |
52-Week High | $453.73 | $105.35 |
52-Week Low | $257.05 | $73.75 |
Typical Hold Time | 28 Days | 63 Days |
Enterprise Value | $13.37B | $131.58B |
Dividend Yield | 2.08% | 3.28% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HII trades at $260.67, down 1.17% with bearish technical signals but strong fundamentals. The company shows consistent earnings beats, with Q2 2026 EPS of $5.27 exceeding expectations by 39%. Recent contract wins including a $5.1 billion aircraft carrier overhaul and 10 unmanned vessel orders provide substantial revenue visibility. Valuation metrics appear reasonable with P/E of 15.78 and P/S of 0.79, while profitability metrics show ROE of 12.97% and net margin of 5.01%.
The investment case balances strong defense contracting fundamentals against technical weakness. Analyst consensus targets $363.67 (39% upside) with 40.7% buy ratings, though technical indicators show bearish momentum. Key risks include execution on large contracts and defense budget uncertainties, while catalysts include continued contract wins and autonomous technology expansion.
Medtronic (MDT) trades at $87.80, up 2.68% today, with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with a 13.93% net income margin and consistent dividend growth over 49 years. Revenue growth accelerated to $33.54B in 2025, and analyst consensus targets $97.80, implying 11% upside. Recent news highlights regulatory approvals for medical devices and a $4B MiniMed exchange offer.
MDT offers value with a 3.2% dividend yield and reasonable valuation (P/E 21.6), but faces headwinds from technical bearishness and rising debt. The stock's appeal hinges on execution of growth initiatives in cardiovascular and neuroscience segments, though competitive and macroeconomic risks persist.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Huntington Ingalls Industries Inc
Huntington Ingalls is the largest military shipbuilder in the U.S. and a provider of professional services to government and industry partners, specializing in nuclear-powered submarines and aircraft carriers.
Read more on HII →About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →
